- Filter by
- Categories
- Tags
- Show all
- Article
- Confusion
- Contract
- Copyright
- Corporate
- Domain Names
- Employment
- Expungement
- Expungement
- Grey Marketing
- Industrial Designs
- Licensing
- Obviousness
- Opposition
- Passing Off
- Patent
- Patent Infringement
- Patent Strategy
- PM(NOC)
- Procedure
- Prosecution
- Services
- Summary
- Trade Secrets
- Trade-mark
- Use
- Validity
- 3D printing
- 6.08
- abandonment
- abstract
- abstract theorems
- accounting of profits
- acquired distinctiveness
- actions
- actual notice
- agreement
- agreements
- airport security
- ambiguity
- amending
- amendment
- Amendments
- annual maintenance fee
- Anticipation
- application
- application chain
- application fee
- arbitrary
- arbitration
- Assignment
- Australia
- bad faith
- bill
- Bill C-31
- Bill C-43
- Bill C-8
- Bill C-86
- biologics
- Biotech Patents
- book launch
- border measures
- brand
- broadcasting
- budget
- burden of proof
- calculation
- call processing
- Canada
- Canada Gazette
- canadian patent law
- causal link
- cdrp
- CEEO
- certificate of supplementary protection
- champerty
- chemical patent
- ciba
- CIPO
- cira
- Claim Construction
- Class Actions
- college of agents
- combination
- combination drugs
- commissioner
- Common General Knowledge
- complete code
- confidential
- Confidential Information
- confidentiality
- confidentiality order
- conflict of interest
- conflicts
- conflicts of interest
- confusing
- confusingly similar
- confusion
- constitution
- constitutional
- constitutionality
- contract
- contributory infringement
- Copyright
- copyright infringement
- copyright test
- Costs
- counsel
- CSP
- damages
- Data
- Data Protection
- deadline
- deadlines
- defamation
- defences
- delay to market entry
- delayed market entry
- descriptive
- design patents
- designs
- deviation
- digital infringement
- disclosure
- distinctive
- distinctive feature
- distinctiveness
- diversity
- division of powers
- DNA Patents
- domain
- domain names
- dosage range
- Double Patenting
- doubtful cases
- due care
- e-commerce
- Early dismissal
- errors
- essentiality of elements
- Ethics
- Europe
- Evidence
- examination quality
- examination statistics
- expert
- expert blinding
- expert evidence
- Experts
- expiry
- Expungement
- extraterritoriality
- federal court
- federal court of appeal
- fee
- fees
- file wrapper
- filing
- filing fee
- financial services
- foreign issue estoppel
- forum selection
- fraud
- Free World Trust
- funding
- future infringement
- generics
- geographical indications
- global
- Good Faith
- government
- grace period
- grey marketing
- Hague
- hearsay
- hearsay evidence
- Honest Contractual Performance
- human use
- ICSID
- Illegality
- Improver
- imunity
- Indefiniteness
- Inducement
- industrial designs
- infringement
- inherent distinctiveness
- injunction
- Injunctions
- Innovation
- insufficiency
- insufficient disclosure
- intellectual property
- intellectual property rights
- intent
- Inter Partes Review
- interlocutory injunction
- Internet
- intra vires
- invalidated
- invalidation
- inventor removal
- inventorship
- IP
- IP management
- ip regime
- IP Strategy
- IPO
- ISP
- IT patent
- ITC
- Jurisdiction
- Late fee
- law
- law firm
- Legal Retainer
- legal test
- legislative reform
- legitimate interest
- license
- licensee
- Licensing
- limitation periods
- litigation
- litigation evidence
- litigation funding agreement
- madrid
- maintenance
- material facts
- Methods of Medical Treatment
- minister of health
- minorities
- misleading
- monopoly
- motion
- Motion to dismiss
- Motion to strike
- NAFTA
- national phase entry
- new act
- no chance of success
- non-infringing alternative
- non-statutory subject matter
- notice of allegation
- notice to rectify
- novelty
- obvious to try
- Obviousness
- official mark
- official marks
- on-sale
- on-sale bar
- Online
- ontario
- opposition
- outsourcing
- Overbreadth
- overlapping
- overpromising
- ownership
- Ownership & Inventorship
- PAB
- Passing Off
- Patent
- patent act
- patent agent
- Patent Agents
- patent appeal board
- patent application
- patent book
- patent eligibility
- patent infrigement
- patent infringement
- patent law
- patent litigation
- Patent Office
- patent ownership
- patent practicioner
- patent protection
- patent rules
- Patent Strategy
- patent term adjustment
- patent trolls
- Patentable Subject Matter
- patented medicines
- patented medicines prices review board
- patentee
- patents
- PCT
- pharma
- pharmaceutical
- pharmaceutical patent
- pharmaceutical pricing
- plain and obvious
- PLT
- PM(NOC)
- PM(NOC) Damages
- PMNOC Regulations
- PMPRB
- posita
- price regulation
- prices
- prior art
- prior disclosure
- prior disclosure defence
- prior use
- priority
- priority claim
- priority date
- Privilege
- procedure
- Product Specificity
- profit
- prohibited marks
- Promise
- promise doctrine
- proprietor
- prosecution
- protective order
- prothonotaries
- provisional patent
- public sale
- Public Servant
- Punitive Damages
- quantification
- ramped-up sales
- recognition
- Records
- registration
- reinstatement
- relevant date for construction
- remedies
- representation
- requisition
- responding
- risk
- Royalties
- s. 27
- s. 45
- s. 53
- sale
- SCOTUS
- second person
- Secondary Infringement
- secondary meaning
- secret sale
- section 101
- section 28
- Section 45
- section 50
- Section 52
- section 56
- section 7
- security
- selection patents
- seminar
- Services
- settlement
- skilled person
- Software Copyright
- Software Patent
- software patents
- Sound Prediction
- specification
- springboard profits
- SRED
- Standard of Review
- standing
- standing to appeal
- Startups
- statute of monopolies
- statutory subject matter
- strategy
- subject matter
- Sufficiency
- Summary Judgment
- summary trial
- supreme court
- surname
- swiss
- tadalafil
- third party
- time frame
- top patent agent
- TPP
- trade secrets
- trade-mark
- Trade-mark Infringement
- Trade-mark Licensing
- Trade-mark Use
- trade-marks act
- trademark
- Trademark Act
- trademark agent
- trademarks
- Trademarks use
- treaty
- UK
- United States
- unpatentable
- untrue material allegation
- US
- use
- useful article
- USMCA
- USPTO
- Utility
- validity
- variant
- Varying records
- veterinary use
- wenger
- who's who legal
- women
May 2, 2017
May 2, 2017
2017 FCA 9 - The FCA affirmed the FC decision that AstraZeneca’s patent was valid and infringed, accepted Apotex’s appeal with respects to limitation periods, and rejected AstraZeneca’s cross-appeal regarding punitive damages.
July 25, 2014
July 25, 2014
Bauer Hockey Corp v Sport Maska Inc - 2014 FCA 158 - The Court confirmed that punitive damages are available in trade-mark infringement cases, but “[a]llegations of willful and knowing infringement are alone insufficient to support a claim to punitive damages."
July 3, 2014
July 3, 2014
Teva Canada Limited v Pfizer Canada Inc, 2014 FCA 138 - The Court held that punitive and exemplary damages cannot be available where the statutory regime underlying the claim explicitly or implicitly precludes them. This is the case under the PM(NOC) Regulations.